These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7356716)
1. The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response. Gottlieb AA; Maziarz GA; Tamaki N; Sutcliffe SB J Immunol; 1980 Feb; 124(2):885-92. PubMed ID: 7356716 [TBL] [Abstract][Full Text] [Related]
2. In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response. Gottlieb AA; Sutcliffe SB Clin Exp Immunol; 1982 Nov; 50(2):434-41. PubMed ID: 6185262 [TBL] [Abstract][Full Text] [Related]
4. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part I. Introduction. (first of three parts). Ablin RJ Allergol Immunopathol (Madr); 1980; 8(1):53-60. PubMed ID: 6996464 [No Abstract] [Full Text] [Related]
5. [Transfer of delayed type hypersensitivity in guinea pigs]. Smogorzewska E Probl Med Wieku Rozwoj; 1990; 16():167-88. PubMed ID: 2152405 [TBL] [Abstract][Full Text] [Related]
6. Effect of transfer factor on lymphocyte function in anergic patients. Kirkpatrick CH; Rich RR; Smith TK J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419 [TBL] [Abstract][Full Text] [Related]
7. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs]. Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813 [TBL] [Abstract][Full Text] [Related]
8. Mononuclear cells contain human transfer factor as assayed locally on the skin of dogs. Tomar RH; John PA J Immunol; 1979 Aug; 123(2):590-3. PubMed ID: 458148 [TBL] [Abstract][Full Text] [Related]
9. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects. Wilson GB; Fudenberg HH J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877 [TBL] [Abstract][Full Text] [Related]
10. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity. Lawton JW; Darg C; Pepper D; Kay AB J Immunol Methods; 1977; 16(2):119-29. PubMed ID: 881554 [TBL] [Abstract][Full Text] [Related]
11. Augmentation of delayed-type hypersensitivity in antigen-primed guinea pigs by human dialyzable leukocyte extract. Chromatographic and enzymatic characterization of the active principle. Ashorn RG; Marnela KM; Uotila A; Krohn KJ Acta Pathol Microbiol Immunol Scand C; 1982 Dec; 90(6):331-7. PubMed ID: 6763449 [TBL] [Abstract][Full Text] [Related]
12. In vitro studies with "transfer factor": transfer of the cell-migration inhibition correlate of delayed hypersensitivity in humans with cell lysates from humans sensitized to histoplasmin, coccidioidin, or PPD. Paque RE; Kniskern PJ; Dray S; Baram P J Immunol; 1969 Nov; 103(5):1014-21. PubMed ID: 5350964 [No Abstract] [Full Text] [Related]
13. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part II. Reconstituting effects dialyzable leukocyte lysates. (Second of three parts). Schindler TE; Baram P Allergol Immunopathol (Madr); 1980; 8(2):125-9. PubMed ID: 7457287 [No Abstract] [Full Text] [Related]
14. Transfer factor: specific and nonspecific effects and chemical characteristics of dialyzable leukocyte lysates (DLL). Part III. Biochemical characterization. (third of three parts). Ablin RJ Allergol Immunopathol (Madr); 1980; 8(3):203-12. PubMed ID: 7405767 [No Abstract] [Full Text] [Related]
15. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg]. Hashimoto Y; Sekiguchi S Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264 [TBL] [Abstract][Full Text] [Related]
16. Effects of human leukocyte dialysates containing transfer factor in the direct leukocyte migration inhibition (LMI) assay. Borkowsky W; Lawrence HS J Immunol; 1979 Oct; 123(4):1741-8. PubMed ID: 479597 [No Abstract] [Full Text] [Related]
17. Transfer in vitro of tubercolin hypersensitivity by sensitised lymphocytes. Fazio M; Calabrese F; Giacomasso S; Negri L; Mastromatteo V Panminerva Med; 1993 Jun; 35(2):96-100. PubMed ID: 8414630 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor. Sandler JA; Smith TK; Manganiello VC; Kirkpatrick CH J Clin Invest; 1975 Nov; 56(5):1271-9. PubMed ID: 171284 [TBL] [Abstract][Full Text] [Related]
19. Distinct components in dialyzable leukocyte extracts (DLE) have specific and nonspecific effects on cellular immunity as shown by leukocyte migration inhibition. Wilson GB; Fudenberg HH; Bahm VJ Trans Assoc Am Physicians; 1978; 91():295-332. PubMed ID: 754397 [No Abstract] [Full Text] [Related]
20. Delayed-type hypersensitivity skin testing. A review. Ahmed AR; Blose DA Arch Dermatol; 1983 Nov; 119(11):934-45. PubMed ID: 6639116 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]